13F-HR filed by TUDOR INVESTMENT CORP ET AL
TUDOR INVESTMENT CORP ET AL filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 1,015 holding rows worth $2,871,493,000.
- Accession
- 0000950123-18-008802
- Filer
- CIK 923093
- Filed
- 2018-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2018
A holdings report, 1,015 entries on the cover page, a total value of $2,871,493,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,871,493,000 with VALUE read as thousands by filing date, 13F file number 028-04356. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APPLIED GENETIC TECHNOL CORP | 03820J100 | COM | 14,839 | $55,000 | thousands by filing date | |
| FRED S INC CLASS A | 356108100 | COM | 22,969 | $52,000 | thousands by filing date | |
| ARATANA THERAPEUTICS INC | 03874P101 | COM | 10,463 | $44,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 19,066 | $43,000 | thousands by filing date | |
| GTY TECHNOLOGY HOLDINGS INC | G4182A128 | *W EXP 10/25/202 | 33,332 | $42,000 | thousands by filing date | call |
| KINROSS GOLD CORP | 496902404 | COM | 10,893 | $41,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 10,980 | $41,000 | thousands by filing date | |
| ARC DOCUMENT SOLUTIONS INC | 00191G103 | COM | 21,551 | $38,000 | thousands by filing date | |
| MANNING + NAPIER INC | 56382Q102 | CL A | 12,147 | $38,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 65,439 | $33,000 | thousands by filing date | |
| VERSARTIS INC | 92529L102 | COM | 12,765 | $26,000 | thousands by filing date | |
| SEQUENTIAL BRNDS GROUP I | 81734P107 | COM | 13,280 | $26,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 17,381 | $23,000 | thousands by filing date | |
| NAVIDEA BIOPHARMACEUTICALS I | 63937X103 | COM | 46,539 | $11,000 | thousands by filing date | |
| RAIT FINANCIAL TRUST | 749227609 | COM NEW | 66,662 | $6,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-18-008802 | this filing | 2018-08-14 | acceptance time not in the bulk data set |